Last month (May 2025), Novo Nordisk and Septerna, a San Francisco, California-based bio/pharmaceutical company focused on GCPRs, formed an exclusive global collaboration and license agreement to discover, develop, and commercialize oral small-molecule medicines for treating obesity, Type 2 diabetes, and other cardiometabolic diseases, in a deal worth up to $2.2 billion ($200 million upfront and near-term funding and $2 billion in milestone payments)
Lecithin Berdasarkan penelitian, lecithin diketahui bermanfaat untuk mengatasi pigmentasi kulit dan mencegah pembentukan melanin sehingga mampu mencerahkan kulit
However, carbohydrate counting is a challenging task and prone to errors, even for trained patients with type 1 diabetes (4346)
18 Read more: Influenced: How persuasion powers purchasing decisions A game-changer for the economy Its rare for a single class of drugs to affect so many aspects of daily life, but GLP-1 medications are proving to be more than just a medical breakthrough
Mein Konto Merkzettel 0 Warenkorb Kontakt Ein guter Draht zu unseren Kunden ist uns sehr wichtig